GU Cancers 2020 | Groundbreaking improvements in RCC treatment

Rana McKay

Rana McKay, MD, University of California, San Diego, CA, discusses the ways in which we can optimize first-line systemic therapy selection in the treatment of renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter